AwesomeCapital
Tuesday, March 31, 2026
Democrat Kings Want Our Heads
›
by J.B. Shurk American leftists held another “No Kings” rally last weekend. Democrats and their ideological allies gathered in city parks ...
FDA Issues Alert on Liver Injuries Linked to Vasculitis Drug, Following Withdrawal Request
›
US regulators issued a new alert about liver injury, including fatal cases, linked to avacopan (Tavneos), a medicine for a rare autoim...
RFK Jr. Says Hospitals Must Serve Healthier Food
›
by Zachary Stieber via The Epoch Times (emphasis ours), U.S. health officials on March 30 informed hospitals they must provide patients w...
Another Greek Tanker Sneaks Through Strait Of Hormuz
›
Another Greek-controlled oil tanker has crossed the Strait of Hormuz, despite Iran's declaration that only "friendly" vessel...
Trial Breathes New Life Into Neurotrophins as Target in Osteoarthritis
›
Osteoarthritis (OA) pain is currently treated with analgesics of only limited efficacy and that come with significant adverse effects when...
ImmunityBio $100 m financing, including $75 m non-dilutive
›
ImmunityBio announces $100 million financing, including $75 million non-dilutive funding Financi ng will support global expansion and advanc...
Palvella Phase 3 rapamycin trial in microcystic lymphatic malformations positive results, backs 1st-line use
›
Palvella plans an H2 2026 NDA filing for QTORIN rapamycin in microcystic lymphatic malformations. Positive Phase III CELVA results for QTO...
‹
›
Home
View web version